Safety of Granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: An open-label, phase I study

Cell Transplantation

Volumn 22, Issue SUPPL.1, 2013, Pages

  Derakhshanrad, Nazi ^a   Saberi, Hooshang ^a   Yekaninejad, Mir Saeed ^a,b   Eskandari, Ghazale ^a   Mardani, Azam ^a   Rahdari, Fereshte ^a   Meybodi, Keyvan Tayebi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Granulocyte colony stimulating factor (G CSF); Neuroprotective therapy; Rehabilitation; Spinal cord injury (SCI)

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARM; ARTICLE; AUTONOMIC DYSREFLEXIA; BLADDER AND BOWEL MANAGEMENT; BONE PAIN; CHILL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DAILY LIFE ACTIVITY; DRUG ERUPTION; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART PALPITATION; HUMAN; INTERNATIONAL ASSOCIATION OF NEURORESTORATOLOGY SPINAL CORD INJURY FUNCTIONAL RATING SCALE; LEG; LEUKOCYTE; LEUKOCYTE COUNT; MALE; NAUSEA; NEUROPATHIC PAIN; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PINPRICK SENSORY SCORE; PRIORITY JOURNAL; RATING SCALE; SENSORIMOTOR FUNCTION; SPASTICITY; SPINAL CORD INDEPENDENCE MEASURE III; SPINAL CORD INJURY; TRANSLATIONAL RESEARCH;

ADOLESCENT; ADULT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; SPINAL CORD INJURIES; YOUNG ADULT;

EID: 84890341113     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X672109     Document Type: Article

References (60)

1. Aidinoff, E.; Front, L.; Itzkovich, M.; Bluvshtein, V.; Gelernter, I.; Hart, J.; Biering-Sorensen, F.; Weeks, C.; Laramee, M. T.; Craven, C.; Hitzig, S. L.; Glaser, E.; Zeilig, G.; Aito, S.; Scivoletto, G.; Mecci, M.; Chadwick, R. J.; El Masry, W. S.; Osman, A.; Glass, C. A.; Soni, B. M.; Gardner, B. P.; Savic, G.; Bergström, E. M.; Silva, P.; Catz, A. Expected spinal cord independence measure, third version, scores for various neurological levels after complete spinal cord lesions. Spinal Cord 49(8):893-896; 2011.
2. Bouhy, D.; Malgrange, B.; Multon, S.; Poirrier, A. L.; Scholtes, F.; Schoenen, J.; Franzen, R. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20(8):1239-1241; 2006.
3. Brines, M.; Grasso, G.; Fiordaliso, F.; Sfacteria, A.; Ghezzi, P.; Fratelli, M.; Latini, R.; Xie, Q. W.; Smart, J.; Su-Rick, C. J.; Pobre, E.; Diaz, D.; Gomez, D.; Hand, C.; Coleman, T.; Cerami, A. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. USA 101(41):14907-14912; 2004.
4. Callera, F.; do Nascimento, R. X. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: A preliminary safety study. Exp. Hematol. 34(2):130-131; 2006.
5. Chen, W. F.; Jean, Y. H.; Sung, C. S.; Wu, G. J.; Huang, S. Y.; Ho, J. T.; Su, T. M.; Wen, Z. H. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogenactivated protein kinase and Akt pathways. Neuroscience 153(1):31-43; 2008.
6. Chen, W. F.; Sung, C. S.; Jean, Y. H.; Su, T. M.; Wang, H. C.; Ho, J. T.; Huang, S. Y.; Lin, C. S.; Wen, Z. H. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: Role of glutamate transporters. Neuroscience 165(4):1217-1232; 2010.
7. Chiodo, A. E.; Scelza, W. M.; Kirshblum, S. C.; Wuermser, L. A.; Ho, C. H.; Priebe, M. M. Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch. Phys. Med. Rehabil. 88(3 Suppl 1):S76-583; 2007.
8. Dawson, J.; Shamley, D.; Jamous, M. A. A structured review of outcome measures used for the assessment of rehabilitation interventions for spinal cord injury. Spinal Cord 46(12):768-780; 2008.
9. De Freria, C. M.; Barbizan, R.; De Oliveira, A. L. Granulocyte colony stimulating factor neuroprotective effects on spinal motoneurons after ventral root avulsion. Synapse 66(2): 128-141; 2012.
10. Dittgen, T.; Pitzer, C.; Plaas, C.; Kirsch, F.; Vogt, G.; Laage, R.; Schneider, A. Granulocyte-colony stimulating factor (G-CSF) improves motor recovery in the rat impactor model for spinal cord injury. PLoS One 7(1):e29880; 2012.
11. Divani, A. A.; Hussain, M. S.; Magal, E.; Heary, R. F.; Qureshi, A. I. The use of stem cells' hematopoietic stimulating factors therapy following spinal cord injury. Ann. Biomed. Eng. 35(10):1647-1656; 2007.
12. Farin, A.; Liu, C. Y.; Langmoen, I. A.; Apuzzo, M. L. Biological restoration of central nervous system architecture and function: Part 3-Stem cell-and cell-based applications and realities in the biological management of central nervous system disorders: Traumatic, vascular, and epilepsy disorders. Neurosurgery 65(5):831-859; discussion 859; 2009.
13. Fawcett, J. W.; Curt, A.; Steeves, J. D.; Coleman, W. P.; Tuszynski, M. H.; Lammertse, D.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Ditunno, J.; Dobkin, B. H.; Havton, L. A.; Ellaway, P. H.; Fehlings, M. G.; Privat, A.; Grossman, R.; Guest, J. D.; Kleitman, N.; Nakamura, M.; Gaviria, M.; Short, D. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45(3):190-205; 2007.
14. Fehlings, M. G.; Vawda, R. Cellular treatments for spinal cord injury: The time is right for clinical trials. Neurotherapeutics 8(4):704-720; 2011.
15. Guo, X.; Bu, X.; Li, Z.; Yan, Z.; Jiang, J.; Zhou, Z. Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colonystimulating factor in experimental spinal injury. Int. J. Neurosci. 122(12):723-733; 2012.
16. Ha, Y.; Kim, Y. S.; Cho, J. M.; Yoon, S. H.; Park, S. R.; Yoon, D. H.; Kim, E. Y.; Park, H. C. Role of granulocytemacrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2(1):55-61; 2005.
17. Ha, Y.; Park, H. S.; Park, C. W.; Yoon, S. H.; Park, S. R.; Hyun, D. K.; Kim, E. Y.; Park, H. C. Synthes Award for Resident Research on Spinal Cord and Spinal Column Injury: Granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. Clin. Neurosurg. 52:341-347; 2005.
18. Harada, M.; Qin, Y.; Takano, H.; Minamino, T.; Zou, Y.; Toko, H.; Ohtsuka, M.; Matsuura, K.; Sano, M.; Nishi, J.; Iwanaga, K.; Akazawa, H.; Kunieda, T.; Zhu, W.; Hasegawa, H.; Kunisada, K.; Nagai, T.; Nakaya, H.; Yamauchi-Takihara, K.; Komuro, I. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11(3):305-311; 2005.
19. Hawryluk, G. W.; Rowland, J.; Kwon, B. K.; Fehlings, M. G. Protection and repair of the injured spinal cord: A review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg. Focus 25(5):E14; 2008.
20. Hayashi, K.; Ohta, S.; Kawakami, Y.; Toda, M. Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF. Neurosci. Res. 64(1):96-103; 2009.
21. Henriques, A.; Pitzer, C.; Dittgen, T.; Klugmann, M.; Dupuis, L.; Schneider, A. CNS-targeted viral delivery of G-CSF in an animal model for ALS: Improved efficacy and preservation of the neuromuscular unit. Mol. Ther. 19(2):284-292; 2011.
22. Henriques, A.; Pitzer, C.; Dupuis, L.; Schneider, A. G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice. BMC Neurosci. 11:25; 2010.
23. Huang, X.; Choi, J. K.; Park, S. R.; Ha, Y.; Park, H.; Yoon, S. H.; Park, H. C.; Park, J. O.; Choi, B. H. GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins. Neurosci. Res. 58(1):50-57; 2007.
24. Huang, X.; Kim, J. M.; Kong, T. H.; Park, S. R.; Ha, Y.; Kim, M. H.; Park, H.; Yoon, S. H.; Park, H. C.; Park, J. O.; Min, B. H.; Choi, B. H. GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J. Neurol. Sci. 277(1-2):87-97; 2009.
25. Huang, H.; Xi, H.; Chen, L.; Zhang, F.; Liu, Y. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 21(Suppl 1):S23-31; 2012.
26. Hyun, J. K.; Kim, H. W. Clinical and experimental advances in regeneration of spinal cord injury. J. Tissue Eng. 2010:650857; 2010.
27. Itzkovich, M.; Gelernter, I.; Biering-Sorensen, F.; Weeks, C.; Laramee, M. T.; Craven, B. C.; Tonack, M.; Hitzig, S. L.; Glaser, E.; Zeilig, G.; Aito, S.; Scivoletto, G.; Mecci, M.; Chadwick, R.J.; El Masry, W. S.; Osman, A.; Glass, C. A.; Silva, P.; Soni, B. M.; Gardner, B. P.; Savic, G.; Bergström, E. M.; Bluvshtein, V.; Ronen, J.; Catz, A. The Spinal Cord Independence Measure (SCIM) version III: Reliability and validity in a multi-center international study. Disabil. Rehabil. 29(24):1926-1933; 2007.
28. Johnson, R. L.; Brooks, C. A.; Whiteneck, G. G. Cost of traumatic spinal cord injury in a population-based registry. Spinal Cord 34(8):470-480; 1996.
29. Kawabe, J.; Koda, M.; Hashimoto, M.; Fujiyoshi, T.; Furuya, T.; Endo, T.; Okawa, A.; Yamazaki, M. Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats: Laboratory investigation. J. Neurosurg Spine 15(4):414-421; 2011.
30. Kim, H. J.; Oh, J. S.; An, S. S.; Pennant, W. A.; Gwak, S. J.; Kim, A. N.; Han, P. K.; Yoon, D. H.; Kim, K. N.; Ha, Y. Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury. Gene Ther. 19(5):513-521; 2012.
31. Kirshblum, S. C.; Priebe, M. M.; Ho, C. H.; Scelza, W. M.; Chiodo, A. E.; Wuermser, L. A. Spinal cord injury medicine. 3. Rehabilitation phase after acute spinal cord injury. Arch. Phys. Med. Rehabil. 88(3 Suppl 1):S62-S70; 2007.
32. Koda, M.; Nishio, Y.; Kamada, T.; Someya, Y.; Okawa, A.; Mori, C.; Yoshinaga, K.; Okada, S.; Moriya, H.; Yamazaki, M. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 1149:223-231; 2007.
33. Lamanna, J. J.; Donnelly, E. M.; Oshinski, J. N.; Boulis, N. M.; Federici, T. Pre-clinical validation of superparamagnetic iron oxide nanoparticle-labeled neural stem cells for in vivo tracking and post-mortem identification in the spinal cord. Neurosurgery 71(2):E569; 2012.
34. Lammertse, D.; Tuszynski, M. H.; Steeves, J. D.; Curt, A.; Fawcett, J. W.; Rask, C.; Ditunno, J. F.; Fehlings, M. G.; Guest, J. D.; Ellaway, P. H.; Kleitman, N.; Blight, A. R.; Dobkin, B. H.; Grossman, R.; Katoh, H.; Privat, A.; Kalichman, M.; International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Clinical trial design. Spinal Cord 45(3):232-242; 2007.
35. Lee, J. S.; Yang, C. C.; Kuo, Y. M.; Sze, C. I.; Hsu, J. Y.; Huang, Y. H.; Tzeng, S. F.; Tsai, C. L.; Chen, H. H.; Jou, I. M. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury. Spine 37(1):10-17; 2012.
36. Luo, J.; Zhang, H. T.; Jiang, X. D.; Xue, S.; Ke, Y. Q. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir. 151(11):1483-1492; 2009.
37. Maynard, Jr., F. M.; Bracken, M. B.; Creasey, G.; Ditunno, Jr., J. F.; Donovan, W. H.; Ducker, T. B.; Garber, S. L.; Marino, R. J.; Stover, S. L.; Tator, C. H.; Waters, R. L.; Wilberger, J. E.; Young, W. International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord 35(5):266-274; 1997.
38. McKinley, W. O.; Jackson, A. B.; Cardenas, D. D.; DeVivo, M. J. Long-term medical complications after traumatic spinal cord injury: A regional model systems analysis. Arch. Phys. Med. Rehabil. 80(11):1402-1410; 1999.
39. Nefussy, B.; Artamonov, I.; Deutsch, V.; Naparstek, E.; Nagler, A.; Drory, V. E. Recombinant human granulocytecolony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study. Amyotroph. Lateral Scler. 11(1-2):187-193; 2010.
40. Nishio, Y.; Koda, M.; Kamada, T.; Someya, Y.; Kadota, R.; Mannoji, C.; Miyashita, T.; Okada, S.; Okawa, A.; Moriya, H.; Yamazaki, M. Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J. Neuropathol. Exp. Neurol. 66(8):724-731; 2007.
41. Osada, T.; Watanabe, M.; Hasuo, A.; Imai, M.; Suyama, K.; Sakai, D.; Kawada, H.; Matsumae, M.; Mochida, J. Efficacy of the coadministration of granulocyte colonystimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J. Neurosurg. Spine 13(4):516-523; 2010.
42. Pan, H. C.; Cheng, F. C.; Lai, S. Z.; Yang, D. Y.; Wang, Y. C.; Lee, M. S. Enhanced regeneration in spinal cord injury by concomitant treatment with granulocyte colony-stimulating factor and neuronal stem cells. J. Clin. Neurosci. 15(6): 656-664; 2008.
43. Pan, H. C.; Wu, H. T.; Cheng, F. C.; Chen, C. H.; Sheu, M. L.; Chen, C. J. Potentiation of angiogenesis and regeneration by G-CSF after sciatic nerve crush injury. Biochem. Biophys. Res. Commun. 382(1):177-182; 2009.
44. Park, H. C.; Shim, Y. S.; Ha, Y.; Yoon, S. H.; Park, S. R.; Choi, B. H.; Park, H. S. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 11(5-6):913-922; 2005.
45. Pitzer, C.; Klussmann, S.; Kruger, C.; Letellier, E.; Plaas, C.; Dittgen, T.; Kirsch, F.; Stieltjes, B.; Weber, D.; Laage, R.; Martin-Villalba, A.; Schneider, A. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. J. Neurochem. 113(4):930-942; 2010.
46. Saberi, H.; Firouzi, M.; Habibi, Z.; Moshayedi, P.; Aghayan, H. R.; Arjmand, B.; Hosseini, K.; Razavi, H. E.; Yekaninejad, M. S. Safety of intramedullary Schwann cell ransplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J. Neurosurg. Spine 15(5): 515-525; 2011.
47. Sakuma, T.; Yamazaki, M.; Okawa, A.; Takahashi, H.; Kato, K.; Hashimoto, M.; Hayashi, K.; Furuya, T.; Fujiyoshi, T.; Kawabe, J.; Mannoji, C.; Kadota, R.; Hashimoto, M.; Takahashi, K.; Koda, M. Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: A phase I and IIa clinical trial. Eur. Spine J. 21(3):482-489; 2012.
48. Sakuma, T.; Yamazaki, M.; Okawa, A.; Takahashi, H.; Kato, K.; Hashimoto, M.; Hayashi, K.; Furuya, T.; Fujiyoshi, T.; Kawabe, J.; Mannoji, C.; Miyashita, T.; Kadota, R.; Someya, Y.; Ikeda, O.; Yamauchi, T.; Hashimoto, M.; Aizawa, T.; Ono, A.; Imagama, S.; Kanemura, T.; Hanaoka, H.; Takahashi, K.; Koda, M. Neuroprotective therapy using granulocyte colonystimulating factor for patients with worsening symptoms of thoracic myelopathy: A multicenter prospective controlled trial. Spine 37(17):1475-1478; 2012.
49. Sanli, A. M.; Serbes, G.; Caliskan, M.; Kaptanoglu, E.; Sargon, M. F.; Kilinc, K.; Besalti, O.; Sekerci, Z. Effect of granulocyte-colony stimulating factor on spinal cord tissue after experimental contusion injury. J. Clin. Neurosci. 17(12):1548-1552; 2010.
50. Shyu, W. C.; Lin, S. Z.; Lee, C. C.; Liu, D. D.; Li, H. Granulocyte colony-stimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ 174(7):927-933; 2006.
51. Steeves, J. D.; Lammertse, D.; Curt, A.; Fawcett, J. W.; Tuszynski, M. H.; Ditunno, J. F.; Ellaway, P. H.; Fehlings, M. G.; Guest, J. D.; Kleitman, N.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Dobkin, B. H.; Grossman, R.; Short, D.; Nakamura, M.; Coleman, W. P.; Gaviria, M.; Privat, A.; International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: Clinical trial outcome measures. Spinal Cord 45(3):206-221; 2007.
52. Sykova, E.; Jendelova, P. In vivo tracking of stem cells in brain and spinal cord injury. Prog. Brain Res. 161:367-383; 2007.
53. Sykova, E.; Jendelova, P. Magnetic resonance tracking of transplanted stem cells in rat brain and spinal cord. Neurodegener Dis 3(1-2):62-67; 2006.
54. Takahashi, H.; Yamazaki, M.; Okawa, A.; Sakuma, T.; Kato, K.; Hashimoto, M.; Hayashi, K.; Furuya, T.; Fujiyoshi, T.; Kawabe, J.; Yamauchi, T.; Mannoji, C.; Miyashita, T.; Kadota, R.; Hashimoto, M.; Ito, Y.; Takahashi, K.; Koda, M. Neuroprotective therapy using granulocyte colonystimulating factor for acute spinal cord injury: A phase I/IIa clinical trial. Eur. Spine J. 21(12):2580-2587; 2012.
55. Thuret, S.; Moon, L. D.; Gage, F. H. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7(8):628-643; 2006.
56. Tuszynski, M. H.; Steeves, J. D.; Fawcett, J. W.; Lammertse, D.; Kalichman, M.; Rask, C.; Curt, A.; Ditunno, J. F.; Fehlings, M. G.; Guest, J. D.; Ellaway, P. H.; Kleitman, N.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Dobkin, B. H.; Grossman, R.; Privat, A.; International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 45(3):222-231; 2007.
57. Urdzikova, L.; Likavcanova-Masinova, K.; Vanecek, V.; Ruzicka, J.; Sedy, J.; Sykova, E.; Jendelova, P. Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat. Cytotherapy 13(9):1090-1104; 2011.
58. Yamasaki, R.; Tanaka, M.; Fukunaga, M.; Tateishi, T.; Kikuchi, H.; Motomura, K.; Matsushita, T.; Ohyagi, Y.; Kira, J. Restoration of microglial function by granulocytecolony stimulating factor in ALS model mice. J. Neuroimmunol. 229(1-2):51-62; 2010.
59. Yoon, S. H.; Shim, Y. S.; Park, Y. H.; Chung, J. K.; Nam, J. H.; Kim, M. O.; Park, H. C.; Park, S. R.; Min, B. H.; Kim, E. Y.; Choi, B. H.; Park, H.; Ha, Y. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25(8):2066-2073; 2007.
60. Zhang, Y.; Wang, L.; Fu, Y.; Song, H.; Zhao, H.; Deng, M.; Zhang, J.; Fan, D. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10(5-6):430-431; 2009.